Skip to main content
. 2020 Jun 29;11(8):2196–2208. doi: 10.1111/1759-7714.13527

Figure 5.

Figure 5

The contribution of miR‐519d‐3p to the effect of circ_0007385 knockdown in NSCLC cells in vitro. (a) RT‐qPCR measured miR‐519d‐3p level in A549 and H1975 cells transfected with miR‐519d‐3p inhibitor (anti‐miR‐519d‐3p) or its control miR‐NC inhibitor (anti‐NC) (Inline graphic) anti‐NC, (Inline graphic) anti‐miR‐519d‐3p. (bj) A549 and H1975 cells were transfected with sh‐circ or sh‐NC, and cotransfected with sh‐circ and anti‐miR‐519d‐3p, or sh‐circ and anti‐NC. (b and c) CCK‐8 assessed OD450 nm value on 24, 48 and 72 hours (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p; (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p. (d and e) Transwell assays determined the numbers of migratory and invasive cells (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p; (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p. (f) Western blotting detected protein expression of the PCNA, E‐cad and N‐cad (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p; (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p. (gj) A549 and H1975 cells transfected with sh‐circ or sh‐NC were treated with DDP for 48 hours. (g) CCK‐8 measured IC50 of DDP after treatment of 0, 2.5, 5, 10, 20, 40, and 80 μM of DDP (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p. (h) FCM examined apoptosis rate (%) (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p and (i and j) caspase‐3 activity after treatment of 10 μM of DDP (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p; (Inline graphic) sh‐NC, (Inline graphic) sh‐circ, (Inline graphic) sh‐circ+anti‐NC, (Inline graphic) sh‐circ+anti‐miR‐519d‐3p. **P < 0.01.